Nine out of 10 drug prices negotiated by CMS remain more expensive in the U.S. compared to six other high-income countries, according to a study published Dec. 2.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
US negotiated drug prices still higher than other countries: Study
